Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 2—February 2022
Research

Burden of Tick-Borne Encephalitis, Sweden

Daniel SlungeComments to Author , Anders Boman, and Marie Studahl
Author affiliations: University of Gothenburg, Gothenburg, Sweden (D. Slunge, A. Boman, M. Studahl); Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg (M. Studahl)

Main Article

Table 1

Healthcare use and sick leave days for persons with TBE and the matched referent cohort, Sweden, 1998–2014*

Variable Within 3 y before TBE After TBE
Within 1 y Within 3 y Within 5 y
Days hospitalized
Case cohort, mean (no.) 1.35 (2,228) 11.50 (2,274) 12.73 (1,863) 14.69 (1,466)
Referent cohort, mean (no.) 2.07 (6,684) 1.12 (6,822) 3.27 (5,589) 5.64 (4,404)
Difference in means
0.28
10.38†
9.46†
9.05†
Specialist outpatient visits
Case cohort, mean (no.) 3.92 (2,228) 3.65 (2,270) 6.78 (1,863) 9.45 (1,466)
Referent cohort, mean (no.) 3.31 (6,684) 1.22 (6,810) 3.53 (5,583) 5.74 (4,398)
Difference in means
0.62†
2.42†
3.25†
3.71†
Days of sick leave
Case cohort, mean (no.) 63.3 (1406) 66.0 (1,434) 122.6 (1,169) 144.0 (902)
Referent cohort, mean (no.) 51.4 (2765) 10.7 (2,802) 45.9 (2,286) 78.1 (1,793)
Difference in means
11.82‡
55.32†
76.66†
65.85†
Primary healthcare visits
Case cohort, mean (no.) 9.19 (280) 6.44 (276) 14.43 (228) 23.29 (175)
Referent cohort, mean (no.) 10.55 (779) 3.90 (763) 11.54 (638) 19.55 (502)
Difference in means −1.36 2.54† 2.89§ 3.74

*TBE, tick-borne encephalitis. †Significance at the 1% level. ‡Significance at the 5% level. §Significance at the 10% level.

Main Article

Page created: December 02, 2021
Page updated: January 24, 2022
Page reviewed: January 24, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external